Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
Recruiting now
Conditions studied: Myocardial Infarction, Percutaneous Transluminal Coronary Angioplasty, Coronary Artery Bypass, Stable Angina, Heart Failure, Valve Disease, Heart, Cardiac Rehabilitation, Stent
In brief
The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximum metabolic activity (MET's), diabetic management, tobacco cessation, lipid, blood pressure, and psychosocial management. These tasks will be accomplished through concurrent conversations between patients and their therapist's utilizing telemedicine with observed exercise training.
Key facts
- Study ID
- NCT05972070
- Run by
- ROM Technologies, INC
- People needed
- 500
- Starts
- 2023-06-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2025-07-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Over the age of 18
- NYHA Functional Class I, II,
- Recent (within 60 days) status post coronary artery revascularization for atherosclerotic coronary artery disease (coronary artery bypass grafting or percutaneous coronary revascularization with stent implantation)
- Candidate for traditional center-based cardiac rehabilitation
You may not qualify if…
- Under the age of 18
- Adults lacking capacity to consent.
- NYHA Functional Class III, IV
- Acute coronary syndrome
- Systolic heart failure (LV EF <40%)
- Status post cardiac surgery for structural heart disease or heart transplant
- Percutaneous coronary angioplasty
- Adults lacking capacity to consent.
- Pregnant women
Where it is running
- ROMTech — Brookfield, Connecticut, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.